The throughline between Ozempic and Prozac
Good morning! I hope everyone has a week of many cookies and few emails ahead. You’ll hear from me once more this year, tomorrow. How safe is food in the U.S.? In
Study revives debate about unpopular diet for cancer patients
Oncologists have been moving away from the notoriously unpopular neutropenic diet. It requires nearly all food to be cooked to high temperatures — or, as some have described it, “boiled to death”
NIH study was a beacon for the topical steroid withdrawal community. Then, amid federal upheaval, the research stalled
On May 23, 2023, Kelly Barta arrived at the National Institutes of Health to figure out what was wrong with her. In a sense, she already knew: She had diagnosed herself with
American food safety could be headed for a breakdown
The infant botulism outbreak that sickened dozens of babies who drank ByHeart formula is a reminder of how vulnerable we all are to the companies that sell us food — and how
STAT+: 3 key issues to watch at FDA as Makary struggles to stabilize the agency
WASHINGTON — The Food and Drug Administration is in a precarious position as it heads toward 2026. The agency has been mired by high-profile departures, feuds between top leaders, accusations of politicization,
STAT+: Mass General Brigham bolstered its bottom line. Other Mass. hospital groups reported multimillion losses
Despite uncertainty and concern buffeting Massachusetts hospitals, the state’s largest health system saw its finances improve last year, turning a small operating surplus and receiving a boon from investment income. Mass General Brigham
What’s happening to gender-affirming care for trans youth?
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. There’s a ton of news today. Make sure you keep scrolling for
CDC awards grant to controversial Danish researchers with ties to top FDA official
WASHINGTON — The Centers for Disease Control and Prevention has awarded a $1.6 million grant to controversial researchers at the University of Southern Denmark with ties to top Food and Drug Administration official
Facing federal hostility, supervised consumption site points to 1,900 overdose reversals
OnPoint NYC, the nonprofit that was the first in the nation to openly offer supervised drug consumption services, celebrated its fourth anniversary Thursday by trumpeting its positive community impact, making its case
Trump’s marijuana reclassification could boost research, broaden access
President Trump on Thursday signed an executive order directing the federal government to reclassify marijuana as a Schedule III substance, marking a major milestone in American drug policy and choosing sides in